Related by context. Frequent words. (Click for all words.) 72 ® bortezomib 69 refractory chronic lymphocytic 68 Completes Patient Enrollment 68 Initiates Phase II 67 FOLOTYN ® 67 R sorafenib tablets 67 Presents Positive 66 VEGFR2 inhibitor 65 Meets Primary Endpoint 65 Receives Orphan Drug Designation 65 YOUR LOCAL ANIMAL SHELTER 65 Offering Pilates 65 signal detection CTSD 65 anthracycline taxane 65 EGFR expressing mCRC 65 Pivotal Phase III 65 VIVITROL ® 65 recurrent glioblastoma multiforme 65 ThermoDox R 64 sorafenib tablets 64 Cutaneous T 64 orderonlineviagra 64 PNP inhibitor 64 cutaneous T 64 Initiate Phase 64 fitball courses 64 Fast Track Status 64 By JENNIFER RADCLIFFE 63 Entereg R 63 gastrointestinal mucositis 63 Sapacitabine 63 diabetic peripheral neuropathic DPN 63 relapsed refractory multiple myeloma 63 viii insufficient 63 Romidepsin 63 Completes Enrollment 63 please visit http:/www.supergen.com 63 RAPTIVA 63 inflammatory autoimmune diseases 63 rheumatoid arthritis psoriatic arthritis 63 oncolytic virus therapies 62 pediatric Crohn disease 62 metastatic HER2 negative 62 esophageal candidiasis 62 forodesine 62 refractory peripheral T 62 Phase Ib IIa 62 Severe VOD 62 Enrolls First 62 FDA Accepts 62 interferon gamma 1b 62 Dacetuzumab 62 irinotecan containing 62 Coadministration 62 catheter occlusion 62 Inc. NASDAQ QLTI 62 R bortezomib 62 sanofi aventis GlaxoSmithKline 62 overactive bladder AA# 62 #-# rDNA origin 62 Omacetaxine 62 MKC# MT 62 www.incyte.com 62 J Am Acad 62 opioid induced bowel dysfunction 62 huC# DM4 62 HGS ETR2 62 Dyax logo 62 Lubiprostone 62 please visit www.eisai.com 62 EGFR expressing metastatic colorectal 61 Antigen Express website 61 By Thomas Gryta 61 BioGlue R 61 PEGylated anti 61 thetreatment 61 By Priyanka Dayal 61 Study Evaluating 61 gets USFDA nod 61 huN# DM1 61 Patient Enrollment 61 Entereg TM 61 Amrubicin 61 Lambert Eaton Myasthenic 61 Auxilium transmucosal film 61 metastatic colorectal 61 SNT MC# 61 rufinamide 61 Nasdaq MNKD focuses 61 AVASTIN 61 unresectable locally advanced 61 lung pancreatic 61 Methylnaltrexone 61 Fibrillex TM 61 Commences Phase 61 INVESTING IN SECURITIES INVOLVES 61 D aspartate NMDA receptor 61 pseudobulbar affect PBA 61 Inc Therapeutic Competitors 60 Ixempra 60 liposomal formulation